Journal Article
. 2019 Mar;568(7751).
doi: 10.1038/s41586-019-1005-x.

Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism

Jiyoung Lee 1 Ali E Yesilkanal 1 Joseph P Wynne 1 Casey Frankenberger 1 Juan Liu 2 Jielin Yan 1 Mohamad Elbaz 1 Daniel C Rabe 1 Felicia D Rustandy 1 Payal Tiwari 1 Elizabeth A Grossman 3 Peter C Hart 4 Christie Kang 4 Sydney M Sanderson 2 Jorge Andrade 5 Daniel K Nomura 3 Marcelo G Bonini 4 Jason W Locasale 2 Marsha Rich Rosner 6 
Affiliations
  • PMID: 30842661
  •     27 citations

Abstract

Mitochondrial metabolism is an attractive target for cancer therapy1,2. Reprogramming metabolic pathways could improve the ability of metabolic inhibitors to suppress cancers with limited treatment options, such as triple-negative breast cancer (TNBC)1,3. Here we show that BTB and CNC homology1 (BACH1)4, a haem-binding transcription factor that is increased in expression in tumours from patients with TNBC, targets mitochondrial metabolism. BACH1 decreases glucose utilization in the tricarboxylic acid cycle and negatively regulates transcription of electron transport chain (ETC) genes. BACH1 depletion by shRNA or degradation by hemin sensitizes cells to ETC inhibitors such as metformin5,6, suppressing growth of both cell line and patient-derived tumour xenografts. Expression of a haem-resistant BACH1 mutant in cells that express a short hairpin RNA for BACH1 rescues the BACH1 phenotype and restores metformin resistance in hemin-treated cells and tumours7. Finally, BACH1 gene expression inversely correlates with ETC gene expression in tumours from patients with breast cancer and in other tumour types, which highlights the clinical relevance of our findings. This study demonstrates that mitochondrial metabolism can be exploited by targeting BACH1 to sensitize breast cancer and potentially other tumour tissues to mitochondrial inhibitors.

Synergistic antitumor activity of artesunate and HDAC inhibitors through elevating heme synthesis via synergistic upregulation of ALAS1 expression.
Cai-Ping Chen, Kun Chen, +2 authors, Hongbin Sun.
Acta Pharm Sin B, 2019 Oct 28; 9(5). PMID: 31649844    Free PMC article.
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
Yu Wang, Hongying An, +9 authors, Ling He.
Cell Rep, 2019 Nov 07; 29(6). PMID: 31693892    Free PMC article.
Exposing the Underlying Relationship of Cancer Metastasis to Metabolism and Epithelial-Mesenchymal Transitions.
Xin Kang, Jin Wang, Chunhe Li.
iScience, 2019 Nov 19; 21. PMID: 31739095    Free PMC article.
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1.
Laura Casares, Víctor García, +7 authors, Eduardo Muñoz.
Redox Biol, 2019 Sep 14; 28. PMID: 31518892    Free PMC article.
Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1.
Hironari Nishizawa, Mitsuyo Matsumoto, +7 authors, Kazuhiko Igarashi.
J Biol Chem, 2019 Nov 20; 295(1). PMID: 31740582    Free PMC article.
Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways.
Akhileshwar Namani, Kaihua Liu, +5 authors, Xiuwen Tang.
Aging (Albany NY), 2019 Dec 31; 11(24). PMID: 31884422    Free PMC article.
Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.
Navneet Ammal Kaidery, Manuj Ahuja, Bobby Thomas.
Mol Cell Neurosci, 2019 Oct 24; 101. PMID: 31644952    Free PMC article.
Review.
Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway.
Ruijie Sun, Ruiren Zhai, Changlin Ma, Wei Miao.
Cancer Med, 2019 Dec 13; 9(3). PMID: 31830378    Free PMC article.
Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction.
Lin Liu, Fan Wang, +3 authors, Wei-Qiang Gao.
Cell Prolif, 2019 Nov 14; 53(1). PMID: 31721355    Free PMC article.
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion.
Peter Kreuzaler, Yulia Panina, Joanna Segal, Mariia Yuneva.
Mol Metab, 2019 Nov 02; 33. PMID: 31668988    Free PMC article.
Review.
BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression.
Batya Cohen, Hanoch Tempelhof, +12 authors, Michal Neeman.
Life Sci Alliance, 2020 Mar 07; 3(4). PMID: 32132179    Free PMC article.
Drug repurposing for breast cancer therapy: Old weapon for new battle.
Sadhna Aggarwal, Sumit Singh Verma, Sumit Aggarwal, Subash Chandra Gupta.
Semin Cancer Biol, 2019 Sep 25;. PMID: 31550502    Free PMC article.
Review.
Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study.
Huang-He He, Jun-Hui Fu, +9 authors, Jian-Xing He.
J Thorac Dis, 2020 Apr 11; 12(3). PMID: 32274150    Free PMC article.
Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway.
Jie Liu, Juan Li, +4 authors, Peijun Liu.
J Cell Mol Med, 2020 Apr 14; 24(10). PMID: 32281270    Free PMC article.
Metformin and Its Benefits for Various Diseases.
Ziquan Lv, Yajie Guo.
Front Endocrinol (Lausanne), 2020 May 20; 11. PMID: 32425881    Free PMC article.
Review.
Indocyanine Green-Parthenolide Thermosensitive Liposome Combination Treatment for Triple-Negative Breast Cancer.
Xin Jin, Xinyue Lu, Zhenhai Zhang, Huixia Lv.
Int J Nanomedicine, 2020 May 23; 15. PMID: 32440118    Free PMC article.
Metformin: the updated protective property in kidney disease.
Qingjun Pan, Xing Lu, +5 authors, Hua-Feng Liu.
Aging (Albany NY), 2020 May 05; 12(9). PMID: 32364526    Free PMC article.
Molecular determinants of drug response in TNBC cell lines.
Nathan M Merrill, Eric J Lachacz, +7 authors, Matthew B Soellner.
Breast Cancer Res Treat, 2019 Oct 28; 179(2). PMID: 31655920    Free PMC article.
Overcoming cancer therapeutic bottleneck by drug repurposing.
Zhe Zhang, Li Zhou, +4 authors, Canhua Huang.
Signal Transduct Target Ther, 2020 Jul 04; 5(1). PMID: 32616710    Free PMC article.
Review.
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.
Mariacarmela Santarpia, Andrés Aguilar, +8 authors, Rafael Rosell.
Cancers (Basel), 2020 Jun 11; 12(6). PMID: 32516941    Free PMC article.
Review.
AMPK Enhances Transcription of Selected Nrf2 Target Genes via Negative Regulation of Bach1.
Katrin Fischhuber, Manuel Matzinger, Elke H Heiss.
Front Cell Dev Biol, 2020 Aug 08; 8. PMID: 32760724    Free PMC article.
Oxidative Stress in Cancer.
John D Hayes, Albena T Dinkova-Kostova, Kenneth D Tew.
Cancer Cell, 2020 Jul 11; 38(2). PMID: 32649885    Free PMC article.
Review.
Genetic analyses support the contribution of mRNA N6-methyladenosine (m6A) modification to human disease heritability.
Zijie Zhang, Kaixuan Luo, +13 authors, Chuan He.
Nat Genet, 2020 Jul 01; 52(9). PMID: 32601472    Free PMC article.
Mitochondrial Metabolism as a Target for Cancer Therapy.
Karthik Vasan, Marie Werner, Navdeep S Chandel.
Cell Metab, 2020 Jul 16; 32(3). PMID: 32668195    Free PMC article.
Review.
Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma.
Jun-Wen Hu, Bin Chen, +4 authors, Bang-De Xiang.
J Cancer, 2020 Oct 10; 11(21). PMID: 33033527    Free PMC article.
Metabolic Constrains Rule Metastasis Progression.
Niccolo' Roda, Valentina Gambino, Marco Giorgio.
Cells, 2020 Sep 17; 9(9). PMID: 32932943    Free PMC article.
Review.
Metformin and oxyphotodynamic therapy as a novel treatment approach for triple-negative breast cancer.
Xiaofeng Pei, Xiaojin Wang, +9 authors, Hongjun Jin.
Ann Transl Med, 2020 Nov 27; 8(18). PMID: 33240987    Free PMC article.